FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2318563886> ?p ?o ?g. }

• W2318563886 endingPage "320" @default.
• W2318563886 startingPage "311" @default.
• W2318563886 abstract "New combinations of antiretrovirals have improved the quality of life and length of survival of patients with HIV infection and AIDS, but they have significant disadvantages. These include considerable toxicity, the development of drug resistance and expense. Successful immunotherapeutic vaccination against HIV would overcome these problems. None of the approaches that have been tried so far have shown a sufficient effect on HIV replication or on immunorestoration to merit their introduction to clinical practice. The most developed agent thus far is Remune, a gp120 depleted whole killed HIV-1 vaccine that has shown marked cytotoxic T lymphocyte responses when administered to man. CD4 count and HIV-1 viral load responses have occurred, but have so far been disappointing in their magnitude. Remune is entering Phase III trials in North America, Europe and the Far East, to determine clinical efficacy. Immunization using recombinant HIV envelope proteins, such as rgp160, for example with VaxSyn, have failed to produce a therapeutic response. Similarly, agents using HIV core antigens, such as p24VLP, have also failed to work. Hence, newer strategies have been tried. Recombinant canarypox vaccines like ALVAC 1452 and highly attenuated vaccinia virus vaccines, such as NYVAC, have been used in combination with HIV genes and peptides. Preliminary results suggest that they might reduce the HIV replication rate, but this needs confirming in larger clinical trials. DNA vaccination has produced encouraging results in monkeys, but the success has not yet been repeated in humans. Other strategies at an early stage include the exploitation of the protective alloimmune response in man. Outside the immunotherapeutic area, other promising new strategies that are being developed in parallel, include the fusion inhibitors, such as T-20. The potential benefits from a successful immunotherapeutic vaccine dictate that this area should, and will receive priority." @default.
• W2318563886 created "2016-06-24" @default.
• W2318563886 creator A5087907945 @default.
• W2318563886 date "2000-10-01" @default.
• W2318563886 modified "2023-10-09" @default.
• W2318563886 title "HIV Immunotherapeutic Vaccines" @default.
• W2318563886 cites W1481708591 @default.
• W2318563886 cites W1502446969 @default.
• W2318563886 cites W1535054993 @default.
• W2318563886 cites W1906564999 @default.
• W2318563886 cites W1966051983 @default.
• W2318563886 cites W1977074734 @default.
• W2318563886 cites W1978406852 @default.
• W2318563886 cites W1986801129 @default.
• W2318563886 cites W1987341410 @default.
• W2318563886 cites W1988328922 @default.
• W2318563886 cites W1994749859 @default.
• W2318563886 cites W2000985920 @default.
• W2318563886 cites W2016468531 @default.
• W2318563886 cites W2017647012 @default.
• W2318563886 cites W2023099234 @default.
• W2318563886 cites W2033757712 @default.
• W2318563886 cites W2039199257 @default.
• W2318563886 cites W2042298936 @default.
• W2318563886 cites W2045837677 @default.
• W2318563886 cites W2049803503 @default.
• W2318563886 cites W2052032107 @default.
• W2318563886 cites W2080706877 @default.
• W2318563886 cites W2089331972 @default.
• W2318563886 cites W2089353735 @default.
• W2318563886 cites W2092985132 @default.
• W2318563886 cites W2097479790 @default.
• W2318563886 cites W2099439824 @default.
• W2318563886 cites W2103239004 @default.
• W2318563886 cites W2111704944 @default.
• W2318563886 cites W2112783842 @default.
• W2318563886 cites W2116372466 @default.
• W2318563886 cites W2116991400 @default.
• W2318563886 cites W2126363927 @default.
• W2318563886 cites W2135073267 @default.
• W2318563886 cites W2143252102 @default.
• W2318563886 cites W2143435033 @default.
• W2318563886 cites W2149218498 @default.
• W2318563886 cites W2151181830 @default.
• W2318563886 cites W2151303894 @default.
• W2318563886 cites W2160534746 @default.
• W2318563886 cites W2161337335 @default.
• W2318563886 cites W2166114226 @default.
• W2318563886 cites W2166883229 @default.
• W2318563886 cites W2287953481 @default.
• W2318563886 cites W2318162832 @default.
• W2318563886 cites W2318576264 @default.
• W2318563886 cites W2320498484 @default.
• W2318563886 cites W2326654059 @default.
• W2318563886 cites W2405120650 @default.
• W2318563886 cites W4210530020 @default.
• W2318563886 cites W4256026931 @default.
• W2318563886 cites W4300123569 @default.
• W2318563886 doi "https://doi.org/10.1177/095632020001100501" @default.
• W2318563886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11142629" @default.
• W2318563886 hasPublicationYear "2000" @default.
• W2318563886 type Work @default.
• W2318563886 sameAs 2318563886 @default.
• W2318563886 citedByCount "9" @default.
• W2318563886 countsByYear W23185638862014 @default.
• W2318563886 crossrefType "journal-article" @default.
• W2318563886 hasAuthorship W2318563886A5087907945 @default.
• W2318563886 hasBestOaLocation W23185638861 @default.
• W2318563886 hasConcept C104317684 @default.
• W2318563886 hasConcept C126322002 @default.
• W2318563886 hasConcept C147483822 @default.
• W2318563886 hasConcept C159047783 @default.
• W2318563886 hasConcept C167508917 @default.
• W2318563886 hasConcept C203014093 @default.
• W2318563886 hasConcept C22070199 @default.
• W2318563886 hasConcept C2522874641 @default.
• W2318563886 hasConcept C2778190748 @default.
• W2318563886 hasConcept C2780195530 @default.
• W2318563886 hasConcept C2780727368 @default.
• W2318563886 hasConcept C2780801004 @default.
• W2318563886 hasConcept C2781356689 @default.
• W2318563886 hasConcept C2909828532 @default.
• W2318563886 hasConcept C2910359755 @default.
• W2318563886 hasConcept C40767141 @default.
• W2318563886 hasConcept C535046627 @default.
• W2318563886 hasConcept C55493867 @default.
• W2318563886 hasConcept C71924100 @default.
• W2318563886 hasConcept C86803240 @default.
• W2318563886 hasConceptScore W2318563886C104317684 @default.
• W2318563886 hasConceptScore W2318563886C126322002 @default.
• W2318563886 hasConceptScore W2318563886C147483822 @default.
• W2318563886 hasConceptScore W2318563886C159047783 @default.
• W2318563886 hasConceptScore W2318563886C167508917 @default.
• W2318563886 hasConceptScore W2318563886C203014093 @default.
• W2318563886 hasConceptScore W2318563886C22070199 @default.
• W2318563886 hasConceptScore W2318563886C2522874641 @default.
• W2318563886 hasConceptScore W2318563886C2778190748 @default.
• W2318563886 hasConceptScore W2318563886C2780195530 @default.

• next